MEPE’s Diverse Effects on Mineralization
- 9 December 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Calcified Tissue International
- Vol. 86 (1), 42-46
- https://doi.org/10.1007/s00223-009-9313-z
Abstract
Matrix extracellular phosphoglycoprotein (MEPE) is an inhibitor of mineralization in situ and in cell cultures where altered expression is associated with oncogenic osteomalacia and hypophosphatemic rickets. The purpose of this study was to determine whether the intact protein or the peptide(s) originating from this protein was responsible for the inhibition. The ability of the intact protein and the acidic, serine- and aspartate-rich MEPE-associated motif (ASARM) peptide to promote or inhibit de novo hydroxyapatite formation and growth of hydroxyapatite seed crystals, in both phosphorylated and dephosphorylated forms, was assessed at room temperature in a dynamic gel diffusion system at 3.5 and 5 days. The most effective nucleator concentration was also examined when associated with fibrillar type I collagen. The phosphorylated intact protein was an effective promoter of mineralization in the gelatin gel diffusion system, while the ASARM peptide was an effective inhibitor. When dephosphorylated both the intact protein and the ASARM peptide had no effect on mineralization. Associated with collagen fibrils, some of the effect of the intact protein was lost. This study demonstrates the importance of posttranslational modification for the site-specific activity of MEPE and its ASARM peptide.Keywords
This publication has 29 references indexed in Scilit:
- Matrix Extracellular Phosphoglycoprotein (MEPE) Is a New Bone Renal Hormone and Vascularization ModulatorEndocrinology, 2009
- MEPE-ASARM Peptides Control Extracellular Matrix Mineralization by Binding to Hydroxyapatite: An Inhibition Regulated by PHEX Cleavage of ASARMJournal of Bone and Mineral Research, 2008
- ASARM‐truncated MEPE and AC‐100 enhance osteogenesis by promoting osteoprogenitor adhesionJournal of Orthopaedic Research, 2008
- Degradation of MEPE, DMP1, and Release of SIBLING ASARM-Peptides (Minhibins): ASARM-Peptide(s) Are Directly Responsible for Defective Mineralization in HYPEndocrinology, 2007
- Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE–ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)Bone, 2005
- Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human boneJournal of Bone and Mineral Metabolism, 2004
- A Synthetic Peptide Fragment of Human MEPE Stimulates New Bone Formation In Vitro and In VivoJournal of Bone and Mineral Research, 2004
- MEPE has the properties of an osteoblastic phosphatonin and minhibinBone, 2004
- MEPE, the Gene Encoding a Tumor-Secreted Protein in Oncogenic Hypophosphatemic Osteomalacia, Is Expressed in BoneGenomics, 2001
- The determination of metals in blood serum by atomic absorption spectroscopy—I: CalciumSpectrochimica Acta, 1960